Global and China Cell-Free DNA (cfDNA) Testing Market Size, Status and Forecast 2020-2026

1 Report Overview

• 1.1 Study Scope
• 1.2 Market Analysis by Type
  • 1.2.1 Global Cell-Free DNA (cfDNA) Testing Market Size Growth Rate by Type: 2020 VS 2026
  • 1.2.2 Donor-Derived Cell-Free DNA (DdcfDNA)
  • 1.2.3 Circulating Cell-Free Tumor DNA (CtDNA)
  • 1.2.4 Cell-Free Fetal DNA (NIPT)
• 1.3 Market by Application
  • 1.3.1 Global Cell-Free DNA (cfDNA) Testing Market Share by Application: 2020 VS 2026
  • 1.3.2 Hospital
  • 1.3.3 Ambulatory Surgical Centers
  • 1.3.4 Cancer Research Institutes
• 1.4 Study Objectives
• 1.5 Years Considered

2 Global Growth Trends

• 2.1 Global Cell-Free DNA (cfDNA) Testing Market Perspective (2015-2026)
• 2.2 Global Cell-Free DNA (cfDNA) Testing Growth Trends by Regions
  • 2.2.1 Cell-Free DNA (cfDNA) Testing Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Cell-Free DNA (cfDNA) Testing Historic Market Share by Regions (2015-2020)
  • 2.2.3 Cell-Free DNA (cfDNA) Testing Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Market Restraints

3 Competition Landscape by Key Players

• 3.1 Global Top Cell-Free DNA (cfDNA) Testing Players by Market Size
  • 3.1.1 Global Top Cell-Free DNA (cfDNA) Testing Players by Revenue (2015-2020)
  • 3.1.2 Global Cell-Free DNA (cfDNA) Testing Revenue Market Share by Players (2015-2020)
• 3.2 Global Cell-Free DNA (cfDNA) Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.3 Players Covered: Ranking by Cell-Free DNA (cfDNA) Testing Revenue
• 3.4 Global Cell-Free DNA (cfDNA) Testing Market Concentration Ratio
  • 3.4.1 Global Cell-Free DNA (cfDNA) Testing Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Top 10 and Top 5 Companies by Cell-Free DNA (cfDNA) Testing Revenue in 2019
• 3.5 Key Players Cell-Free DNA (cfDNA) Testing Area Served
• 3.6 Key Players Cell-Free DNA (cfDNA) Testing Product Solution and Service
• 3.7 Date of Enter into Cell-Free DNA (cfDNA) Testing Market
• 3.8 Mergers & Acquisitions, Expansion Plans

4 Cell-Free DNA (cfDNA) Testing Breakdown Data by Type (2015-2026)

• 4.1 Global Cell-Free DNA (cfDNA) Testing Historic Market Size by Type (2015-2020)
• 4.2 Global Cell-Free DNA (cfDNA) Testing Forecasted Market Size by Type (2021-2026)

5 Cell-Free DNA (cfDNA) Testing Breakdown Data by Application (2015-2026)

• 5.1 Global Cell-Free DNA (cfDNA) Testing Historic Market Size by Application (2015-2020)
• 5.2 Global Cell-Free DNA (cfDNA) Testing Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Cell-Free DNA (cfDNA) Testing Market Size (2015-2026)
• 6.2 North America Cell-Free DNA (cfDNA) Testing Market Size by Type (2015-2020)
• 6.3 North America Cell-Free DNA (cfDNA) Testing Market Size by Application (2015-2020)
• 6.4 North America Cell-Free DNA (cfDNA) Testing Market Size by Country (2015-2020)
  • 6.4.1 United States
  • 6.4.2 Canada

7 Europe

• 7.1 Europe Cell-Free DNA (cfDNA) Testing Market Size (2015-2026)
• 7.2 Europe Cell-Free DNA (cfDNA) Testing Market Size by Type (2015-2020)
• 7.3 Europe Cell-Free DNA (cfDNA) Testing Market Size by Application (2015-2020)
• 7.4 Europe Cell-Free DNA (cfDNA) Testing Market Size by Country (2015-2020)
  • 7.4.1 Germany
  • 7.4.2 France
  • 7.4.3 U.K.
  • 7.4.4 Italy
  • 7.4.5 Russia
  • 7.4.6 Nordic
  • 7.4.7 Rest of Europe

8 China

• 8.1 China Cell-Free DNA (cfDNA) Testing Market Size (2015-2026)
• 8.2 China Cell-Free DNA (cfDNA) Testing Market Size by Type (2015-2020)
• 8.3 China Cell-Free DNA (cfDNA) Testing Market Size by Application (2015-2020)
• 8.4 China Cell-Free DNA (cfDNA) Testing Market Size by Region (2015-2020)
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 South Korea
  • 8.4.4 Southeast Asia
  • 8.4.5 India
  • 8.4.6 Australia
  • 8.4.7 Rest of Asia-Pacific

9 Japan

• 9.1 Japan Cell-Free DNA (cfDNA) Testing Market Size (2015-2026)
• 9.2 Japan Cell-Free DNA (cfDNA) Testing Market Size by Type (2015-2020)
• 9.3 Japan Cell-Free DNA (cfDNA) Testing Market Size by Application (2015-2020)
• 9.4 Japan Cell-Free DNA (cfDNA) Testing Market Size by Country (2015-2020)
  • 9.4.1 Mexico
  • 9.4.2 Brazil

10 Southeast Asia

• 10.1 Southeast Asia Cell-Free DNA (cfDNA) Testing Market Size (2015-2026)
• 10.2 Southeast Asia Cell-Free DNA (cfDNA) Testing Market Size by Type (2015-2020)
• 10.3 Southeast Asia Cell-Free DNA (cfDNA) Testing Market Size by Application (2015-2020)
• 10.4 Southeast Asia Cell-Free DNA (cfDNA) Testing Market Size by Country (2015-2020)
  • 10.4.1 Turkey
  • 10.4.2 Saudi Arabia
  • 10.4.3 UAE
  • 10.4.4 Rest of Middle East & Africa

11 Key Players Profiles

• 11.1 Agilent Technology
  • 11.1.1 Agilent Technology Company Details
  • 11.1.2 Agilent Technology Business Overview
  • 11.1.3 Agilent Technology Cell-Free DNA (cfDNA) Testing Introduction
  • 11.1.4 Agilent Technology Revenue in Cell-Free DNA (cfDNA) Testing Business (2015-2020))
  • 11.1.5 Agilent Technology Recent Development
• 11.2 Allenex
  • 11.2.1 Allenex Company Details
  • 11.2.2 Allenex Business Overview
  • 11.2.3 Allenex Cell-Free DNA (cfDNA) Testing Introduction
  • 11.2.4 Allenex Revenue in Cell-Free DNA (cfDNA) Testing Business (2015-2020)
  • 11.2.5 Allenex Recent Development
• 11.3 Biocept
  • 11.3.1 Biocept Company Details
  • 11.3.2 Biocept Business Overview
  • 11.3.3 Biocept Cell-Free DNA (cfDNA) Testing Introduction
  • 11.3.4 Biocept Revenue in Cell-Free DNA (cfDNA) Testing Business (2015-2020)
  • 11.3.5 Biocept Recent Development
• 11.4 Biodesix
  • 11.4.1 Biodesix Company Details
  • 11.4.2 Biodesix Business Overview
  • 11.4.3 Biodesix Cell-Free DNA (cfDNA) Testing Introduction
  • 11.4.4 Biodesix Revenue in Cell-Free DNA (cfDNA) Testing Business (2015-2020)
  • 11.4.5 Biodesix Recent Development
• 11.5 CareDx
  • 11.5.1 CareDx Company Details
  • 11.5.2 CareDx Business Overview
  • 11.5.3 CareDx Cell-Free DNA (cfDNA) Testing Introduction
  • 11.5.4 CareDx Revenue in Cell-Free DNA (cfDNA) Testing Business (2015-2020)
  • 11.5.5 CareDx Recent Development
• 11.6 Guardant Health
  • 11.6.1 Guardant Health Company Details
  • 11.6.2 Guardant Health Business Overview
  • 11.6.3 Guardant Health Cell-Free DNA (cfDNA) Testing Introduction
  • 11.6.4 Guardant Health Revenue in Cell-Free DNA (cfDNA) Testing Business (2015-2020)
  • 11.6.5 Guardant Health Recent Development
• 11.7 Illumania
  • 11.7.1 Illumania Company Details
  • 11.7.2 Illumania Business Overview
  • 11.7.3 Illumania Cell-Free DNA (cfDNA) Testing Introduction
  • 11.7.4 Illumania Revenue in Cell-Free DNA (cfDNA) Testing Business (2015-2020)
  • 11.7.5 Illumania Recent Development
• 11.8 Invited
  • 11.8.1 Invited Company Details
  • 11.8.2 Invited Business Overview
  • 11.8.3 Invited Cell-Free DNA (cfDNA) Testing Introduction
  • 11.8.4 Invited Revenue in Cell-Free DNA (cfDNA) Testing Business (2015-2020)
  • 11.8.5 Invited Recent Development
• 11.9 Natera
  • 11.9.1 Natera Company Details
  • 11.9.2 Natera Business Overview
  • 11.9.3 Natera Cell-Free DNA (cfDNA) Testing Introduction
  • 11.9.4 Natera Revenue in Cell-Free DNA (cfDNA) Testing Business (2015-2020)
  • 11.9.5 Natera Recent Development
• 11.10 Quest Diagnostics
  • 11.10.1 Quest Diagnostics Company Details
  • 11.10.2 Quest Diagnostics Business Overview
  • 11.10.3 Quest Diagnostics Cell-Free DNA (cfDNA) Testing Introduction
  • 11.10.4 Quest Diagnostics Revenue in Cell-Free DNA (cfDNA) Testing Business (2015-2020)
  • 11.10.5 Quest Diagnostics Recent Development
• 11.11 Roche Holdings
  • 10.11.1 Roche Holdings Company Details
  • 10.11.2 Roche Holdings Business Overview
  • 10.11.3 Roche Holdings Cell-Free DNA (cfDNA) Testing Introduction
  • 10.11.4 Roche Holdings Revenue in Cell-Free DNA (cfDNA) Testing Business (2015-2020)
  • 10.11.5 Roche Holdings Recent Development
• 11.12 Sequenom
  • 10.12.1 Sequenom Company Details
  • 10.12.2 Sequenom Business Overview
  • 10.12.3 Sequenom Cell-Free DNA (cfDNA) Testing Introduction
  • 10.12.4 Sequenom Revenue in Cell-Free DNA (cfDNA) Testing Business (2015-2020)
  • 10.12.5 Sequenom Recent Development
• 11.13 Trovagene
  • 10.13.1 Trovagene Company Details
  • 10.13.2 Trovagene Business Overview
  • 10.13.3 Trovagene Cell-Free DNA (cfDNA) Testing Introduction
  • 10.13.4 Trovagene Revenue in Cell-Free DNA (cfDNA) Testing Business (2015-2020)
  • 10.13.5 Trovagene Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

• 13.1 Research Methodology
  • 13.1.1 Methodology/Research Approach
  • 13.1.2 Data Source
• 13.2 Disclaimer